Showing 1 - 10 of 862
search of an effective therapeutic drug. Experimental drugs developed for other infections, such as Gilead's remdesivir, have … developing broad-spectrum drugs.These drugs, however, confront a market failure: what firm will invest millions developing a drug …-spectrum antiviral drugs developed up to phase III clinical trials in the FDA drug approval process. I also emphasize the importance of …
Persistent link: https://www.econbiz.de/10012837598
States tightly regulate access to alcohol and other substances. During the pandemic and related state of emergency, state and federal governments adopted a variety of regulations affecting this access. State shelter-in-place orders included decisions about whether liquor stores and marijuana...
Persistent link: https://www.econbiz.de/10013249903
Persistent link: https://www.econbiz.de/10012594290
Persistent link: https://www.econbiz.de/10014444172
COVID-19 (Coronavirus Disease-2019) is an international public health problem with a high rate of severe clinical cases. Several treatments are currently being tested worldwide. This paper focuses on anti-malarial drugs such as chloroquine or hydroxychloroquine, which have been currently...
Persistent link: https://www.econbiz.de/10013241099
The COVID-19 pandemic has highlighted problems regarding scarcity of lifesaving medicines. During pandemics and epidemics, a sudden surge in demand for medicines is often unmatched on the supply side. Moreover, the same intellectual property rights that are supposed to incentivize their creation...
Persistent link: https://www.econbiz.de/10013288862
Persistent link: https://www.econbiz.de/10014228474
Persistent link: https://www.econbiz.de/10014314951
Pakistan is one of only three countries that have failed to stop the transmission of poliovirus and experienced a surge … of polio paralysis in 2019. Meanwhile, misconceptions persist about the safety and efficacy of vaccines in Pakistan and …
Persistent link: https://www.econbiz.de/10014321181
Persistent link: https://www.econbiz.de/10014311997